Work began on the construction of AstraZeneca's New Medicine Development and Supplying Complex in Wuxi National Hi-Tech District on Sept 19.
The $50 million project, which forms part of the "China Accelerator" strategy initiated by AstraZeneca in December 2015, will develop and produce small molecule drugs developed by AstraZeneca China and its other research institutions around the world.
This project is also expected to provide a further boost to Wuxi's innovation capacity and the city's biomedical industry.
Since establishing its first facility in Wuxi National Hi-Tech District in 1993, AstraZeneca has played a large role in the area's development and has invested $555 million in the city in total.
As one of the world's largest pharmaceutical companies, AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat a huge variety of disorders.
